Investigating the Efficacy and Mechanisms of Individualized tACS Targeting Anhedonia in Late-Life Depression
RecruitingNCT07637773Phase: NAStarted 2026-03-16
Summary
This project focuses on clinical translational research into personalized transcranial alternating current stimulation (tACS) for treating anhedonia in late-life depression (LLD). Key components inclu
Eligibility
Sex
ALL
Min Age
60 Years
Max Age
None
Locations
Tianjin Anding HospitalTianjin, Tianjin Municipality, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07637773